Yüklüyor......
The Melanosomal Protein PMEL17 as a Target for Antibody Drug Conjugate Therapy in Melanoma
Melanocytes uniquely express specialized genes required for pigment formation, some of which are maintained following their transformation to melanoma. Here we exploit this property to selectively target melanoma with an antibody drug conjugate (ADC) specific to PMEL17, the product of the SILV pigme...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Biochemistry and Molecular Biology
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3397835/ https://ncbi.nlm.nih.gov/pubmed/22613716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M112.361485 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|